Atrial fibrillation market to hit $27.88 billion by 2030
The atrial fibrillation market is expected to grow from $15.1 billion in 2025 to $27.88 billion by 2030, according to The Business Research Company. The forecast points to rising demand for diagnostics, ablation, wearable monitoring and long-term rhythm management as cardiovascular disease rates climb globally.
Why it matters: - Atrial fibrillation is tied to stroke risk and other serious heart complications, so growth in diagnosis and treatment tools has direct patient and health system impact. - The market expansion reflects broader demand for better arrhythmia care as aging populations and cardiovascular disease burden rise. - The forecast suggests more spending on monitoring, procedures and medications across major health systems.
What happened: - The Business Research Company released its Atrial Fibrillation Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the market at $15.1 billion in 2025 and $17.1 billion in 2026. - The market is projected to reach $27.88 billion by 2030, growing at a 13.0% CAGR over the forecast period. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - A free sample is available here. - The full report is available here.
The details: - The report says earlier growth was driven by rising atrial fibrillation incidence among aging populations. - The report also cites better access to cardiac diagnostic tools and wider availability of anticoagulant medications. - Growth in electrophysiology laboratory infrastructure and higher awareness of stroke prevention strategies also supported the market. - Future growth is expected to come from demand for customized arrhythmia treatments. - Wearable cardiac monitors are becoming more common in atrial fibrillation care. - The report points to expansion of hybrid therapeutic approaches and more investment in electrophysiology capabilities. - The report highlights a stronger focus on long-term management of heart rhythm outcomes. - Emerging trends include catheter ablation, advanced cardiac mapping, minimally invasive therapies, expanded pharmacological rhythm control options, and earlier diagnosis and patient monitoring. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report update includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Between the lines: - The market outlook shows a shift from basic diagnosis and drug access toward more device-driven, procedure-based and data-supported care. - North America's lead likely reflects mature infrastructure, while Asia-Pacific's faster growth points to more room for adoption and investment. - The CDC reported in October 2024 that cardiovascular diseases caused 919,032 deaths in the U.S. in 2023, equal to one in every three deaths, which underscores the scale of the clinical need. - The same CDC update said about 805,000 Americans suffer a heart attack annually, reinforcing the broader cardiovascular burden.
What's next: - Market growth is likely to track adoption of ablation, wearables and improved rhythm-monitoring tools. - More investment in electrophysiology services should continue as providers respond to rising case volumes. - The report suggests long-term management strategies will matter more as care shifts toward earlier detection and personalized treatment.
The bottom line: - Atrial fibrillation is moving from a niche cardiac category to a fast-growing global market, with major demand building around diagnostics, treatment precision and ongoing monitoring.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
24/7 Business Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.